Quinoxalines versus indolinones as inhibitors of restenosis.
Levitzki
A
A
D000818:Animals; D006083:Graft Occlusion, Vascular / Q000517:prevention & control*; D017712:Peer Review, Research / Q000592:standards*; D011810:Quinoxalines / Q000627:therapeutic use*; D051381:Rats; D017479:Receptors, Platelet-Derived Growth Factor / Q000037:antagonists & inhibitors; D013552:Swine
D011810:Quinoxalines; C099852:PDGF receptor tyrosine kinase; D017479:Receptors, Platelet-Derived Growth Factor